Bill Paris

Bill Paris is a seasoned Senior Medical Science Liaison with extensive experience in the pharmaceutical industry, currently engaged with Rezolute, Inc. since May 2025. Previously, Bill held similar roles at X4 Pharmaceuticals, F2G, Ultragenyx Pharmaceutical Inc., Chiesi Global Rare Disease, and Genentech, focusing on rare diseases, infectious diseases, and neurology. Bill's expertise encompasses the dissemination of clinical and scientific information and building relationships with key opinion leaders across various therapeutic areas. With a Doctor of Philosophy in Public Health from Walden University, an MBA from Colorado State University, and a B.S. in Industrial Technology from California Polytechnic State University-San Luis Obispo, Bill is well-equipped to advance scientific collaboration and education in healthcare settings.